Tag: capital

BANGKOK, June 25, 2026 /PRNewswire/ -- Rising above the Bangkok skyline and redefining urban living in the heart of the Thai capital, Central Park...

GENEVA, June 25, 2026 /PRNewswire/ -- MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics,...

Project delivered under a US$41 million transaction as part of the 21 MW DC Honeywell portfolio in upstate New York7.01 MW DC ground-mount solar...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY OTHER JURISDICTION WHERE TO DO SO WOULD VIOLATE...

TORONTO, June 25, 2026 /CNW/ - Power Metallic Mines Inc. (the "Company" or "Power Metallic") (TSXV: PNPN) (OTCBB: PNPNF) (Frankfurt: IVV1) is pleased to announce...

BEIJING, June 25, 2026 /PRNewswire/ -- On June 23, two indices gauging prices of yak and Tibetan sheep in northwest China's Qinghai Province were released...

TAIPEI, June 25, 2026 /PRNewswire/ -- Led by the Department of Economic Development, Taipei City Government, the StartUP@Taipei program brought 10 Taipei-based AI companies...

DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 32,500,001 shares of its common stock at a price to the public of $6.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 833,333 shares of its common stock at an offering price of $5.999 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the securities are being offered by Taysha. In addition, Taysha has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering to Taysha are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about June 26, 2026, subject to customary closing conditions.

TORONTO, June 24, 2026 /CNW/ - Jamieson Wellness Inc. ("Jamieson" or the "Company") (TSX: JWEL) acknowledges a recent media report regarding a potential sale...

RALEIGH, N.C., June 24, 2026 /PRNewswire/ -- Cardinal Infrastructure Group, Inc. (the "Company" or "Cardinal") (Nasdaq: CDNL) today announced the pricing of an upsized...